- Home
- HOOD vs SNY Comparison
HOOD vs SNY Comparison
Compare HOOD & SNY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HOOD
- SNY
- Stock Information
- Founded
- HOOD 2013
- SNY 1994
- Country
- HOOD United States
- SNY France
- Employees
- HOOD N/A
- SNY N/A
- Industry
- HOOD Computer Software: Prepackaged Software
- SNY Biotechnology: Pharmaceutical Preparations
- Sector
- HOOD Technology
- SNY Health Care
- Exchange
- HOOD Nasdaq
- SNY Nasdaq
- Market Cap
- HOOD 127.2B
- SNY 116.1B
- IPO Year
- HOOD 2021
- SNY N/A
- Fundamental
- Price
- HOOD $144.91
- SNY $49.11
- Analyst Decision
- HOOD Buy
- SNY Buy
- Analyst Count
- HOOD 23
- SNY 4
- Target Price
- HOOD $109.57
- SNY $61.50
- AVG Volume (30 Days)
- HOOD 44.1M
- SNY 3.9M
- Earning Date
- HOOD 11-05-2025
- SNY 10-24-2025
- Dividend Yield
- HOOD N/A
- SNY 3.25%
- EPS Growth
- HOOD 513.62
- SNY 118.56
- EPS
- HOOD 1.96
- SNY 8.65
- Revenue
- HOOD $3,567,000,000.00
- SNY $53,714,621,258.00
- Revenue This Year
- HOOD $46.05
- SNY $1.53
- Revenue Next Year
- HOOD $20.07
- SNY $7.06
- P/E Ratio
- HOOD $73.78
- SNY $5.69
- Revenue Growth
- HOOD 59.38
- SNY 15.65
- 52 Week Low
- HOOD $22.72
- SNY $44.62
- 52 Week High
- HOOD $153.86
- SNY $60.12
- Technical
- Relative Strength Index (RSI)
- HOOD 70.54
- SNY 54.77
- Support Level
- HOOD $120.46
- SNY $44.62
- Resistance Level
- HOOD $153.83
- SNY $51.05
- Average True Range (ATR)
- HOOD 6.08
- SNY 0.83
- MACD
- HOOD 1.88
- SNY 0.43
- Stochastic Oscillator
- HOOD 74.36
- SNY 68.73
About HOOD Robinhood Markets Inc.
Robinhood Markets Inc is creating a modern financial services platform. It designs its own products and services and delivers them through a single, app-based cloud platform supported by proprietary technology. Its vertically integrated platform has enabled the introduction of new products and services such as cryptocurrency trading, dividend reinvestment, fraud detection, derivatives, fractional shares, recurring investments, and others.
About SNY Sanofi ADS
Sanofi develops and markets drugs with a concentration in immunology, vaccines, and rare diseases. Although the company offers a diverse array of drugs, its highest revenue generator, Dupixent, accounts for approximately 30% of total sales. Profits for this immunology blockbuster drug are shared with Regeneron. About 45% of total revenue comes from the United States, 20% from Europe, and 6% from China.